---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-025070"
form_type: "8-K"
ticker: "OSUR"
cik: "0001116463"
company_name: "ORASURE TECHNOLOGIES INC"
filed_at: "2022-11-14T23:59:59+00:00"
generated_at: "2026-06-21T19:24:43.813282+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# OraSure appoints Kathleen G. Weber Chief Product Officer; Lisa Nibauer resigns as President of Diagnostics

## Summary
- Kathleen G. Weber, previously President of Molecular Solutions, appointed as Chief Product Officer effective Nov 14, 2022.
- Amendment to employment agreement reflects title/duties change and updates definition of Good Reason; severance unchanged.
- Lisa Nibauer resigns as President of Diagnostics effective Nov 11, 2022.
- No details on resignation reason or immediate successor for Diagnostics.

## SEC filing metadata
- accession: 0000950170-22-025070
- form_type: 8-K
- ticker: OSUR
- cik: 0001116463
- company_name: ORASURE TECHNOLOGIES INC
- filed_at: 2022-11-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1116463/000095017022025070/0000950170-22-025070-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1116463/000095017022025070/osur-20221107.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-025070
- JSON: https://secwatch.observer/filing/0000950170-22-025070.json
- Plain text: https://secwatch.observer/filing/0000950170-22-025070.txt

## Key facts
- Executive change
  Kathleen G. Weber was appointed as Chief Product Officer at ORASURE TECHNOLOGIES INC.
  - Action: appointed
  - Role: Chief Product Officer
  source text: On November 7, 2022, the board of directors of OraSure Technologies, Inc. (the “Company”) appointed Kathleen G. Weber, the Company’s current President of Molecular Solutions, as the Company’s Chief Product Officer, effective November 14, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1116463/000095017022025070/0000950170-22-025070-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.